RecruitingNCT02461446
Natural History Study of Individuals With Autism and Germline Heterozygous PTEN Mutations
Sponsor
Boston Children's Hospital
Enrollment
170 participants
Start Date
May 1, 2015
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to determine cross-sectional and longitudinal medical, behavioral, and cognitive differences between PTEN ASD and other groups, as well as to identify cognitive, neural systems, and molecular biomarkers specific to PTEN ASD. In addition, this study will be creating and maintaining a biorepository and linked phenotypic database for PTEN ASD.
Eligibility
Min Age: 18 Months
Inclusion Criteria5
- Individuals above the age of 18 months old at the time of consent who have documentation of a clinical diagnosis of autism spectrum disorder and/or a verified PTEN mutation from a medical or mental health professional for inclusion in the PTEN ASD, PTEN no-ASD or ASD macrocephaly groups.
- Macrocephaly (head circumference greater than or equal to 98th percentile) for inclusion in the ASD macrocephaly group.
- For youths, consent from parents or legal guardian. For adults, consent from self or legal guardian.
- Youths who are able (some young or severely impaired participants may not be able to provide assent) will be asked to provide assent as per IRB guidelines.
- Primary communicative language must be English
Exclusion Criteria4
- Unwilling or unable to comply with study procedures and assessments
- Clinically significant medical disease that would prohibit participation in the study procedures.
- For subjects ELIGIBLE FOR OPTIONAL imaging biomarker assessment: contraindications to 3T MRI scanning, such as metal implants/non-compatible medical devices or medical conditions, including vagus nerve stimulator.
- For subjects ELIGIBLE FOR EEG/ERP biomarker assessment: contraindications to EEG/ERP, such as uncooperative or destructive behaviors preventing lead placement or capture by ERP/VEP equipment. Under age 2 or over 11 at the time of enrollment.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02461446
Related Trials
A Phase 2A Trial of DT402 for Autism Spectrum Disorder
NCT073039071 location
Spanish-language Executive Function Intervention for Children With Autism and/or ADHD
NCT070843241 location
Magnetoencephalography in Children
NCT066685191 location
Trial of Zolpidem for Sleep in Children With Autism
NCT055405741 location
Trial of Diphenhydramine for Sleep in Children With Autism
NCT055016781 location